Our findings revealed that HBMSCs-derived exosomal miR-99b-5p could attenuate the progression of PCa both in vitro and in vivo by regulating IGF1R, suggesting that hBMSCs-derived exosomes might be a novel therapeutic strategy for PCa. The gene discussed is IGF1R; the disease is posterior cortical atrophy.